Molecular Basis for the Neutralization of Tumor Necrosis Factor α by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases
2017 ◽
Vol 18
(1)
◽
pp. 228
◽
2007 ◽
Vol 13
(11)
◽
pp. 1323-1332
◽
2013 ◽
Vol 84
(2)
◽
pp. 136-142
◽
2004 ◽
Vol 279
(43)
◽
pp. 45121-45129
◽